Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05582551 · ClinicalTrials.gov registry record · NA

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

A NA study of Childhood Cancer, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
146
Enrollment target
1
Study location

NCT05582551: Recruiting NA study of Childhood Cancer, sponsored by Washington University School of Medicine.

NCT05582551 is a NA study of Childhood Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 146 participants, below the 1,466-participant average among 23 other Childhood Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05582551, a NA study of Childhood Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
146 participants
Enrollment target
1
Study location

Study Summary

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Conditions Studied

Interventions

  • OTHER Highlighting Patients at Risk for Sensory Screening (HPARSS)

Study Locations (1)

Missouri

  • St. Louis Children's Hospital - Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2023-08-02
Est. Completion 2026-05-31
Phase NA

What NCT05582551 shows while recruiting

NCT05582551 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,466-participant average among 23 other Childhood Cancer trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 1 intervention - of which Highlighting Patients at Risk for Sensory Screening (HPARSS) is the first listed.

NCT05582551 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05582551 about?

NCT05582551 is a clinical study titled "Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors". The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics a...

What is the current status of trial NCT05582551?

This trial is currently recruiting. It is a NA study. The enrollment target is 146 participants. The study started on 2023-08-02. Estimated completion is 2026-05-31.

What conditions does trial NCT05582551 study?

This clinical trial studies the following conditions: Childhood Cancer.

What interventions are being tested in trial NCT05582551?

The interventions under investigation include: Highlighting Patients at Risk for Sensory Screening (HPARSS) (OTHER).

Who is sponsoring clinical trial NCT05582551?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05582551 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05582551's enrollment target sits among peer trials

146 9th of 23 higher than 15 of 23 other Childhood Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05582551, the US trial registry maintained by the National Library of Medicine. NCT05582551 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.